Source: BioSpace

Nanotherapeutics: Nanotherapeutics Announces Name Change To Reflecting The Company???s Ongoing Transformation Into One Of The Top Contract Development And Manufacturing Organizations Of Vaccines And Biologics

Life Sciences Jobs ...

Read full article »
Nanotherapeutics's Competitors | Nanotherapeutics's News | Nanotherapeutics's Financials
Stay up-to-date with the latest news on Nanotherapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Peter H. Khoury's photo - President & CEO of Nanotherapeutics

President & CEO

Peter H. Khoury

CEO Approval Rating

71/100

Read more
Stay up-to-date with the latest news on Nanotherapeutics